ARPA-H Launches Agentic AI Cardiovascular Program
The U.S. ARPA-H is soliciting proposals for ADVOCATE, a multiyear program to develop FDA-authorized agentic AI systems for cardiovascular care, expecting teams to deliver two agents and seek authorization within roughly three years, with a proposal-summary deadline of Feb. 27. Simultaneously, CMS is advancing interoperability standards and the FDA cleared Aidoc’s AI triage detecting 14 acute CT conditions, highlighting regulatory alignment.
Key Points
- 1Launches ADVOCATE to develop two FDA-authorized agentic AI cardiovascular care agents within about three years
- 2Highlights regulatory and infrastructure alignment as CMS and FDA enable patient-facing clinical AI at scale
- 3Requires developers to prioritize interoperable EHR, wearable, and app integration for approval and reimbursement
Scoring Rationale
High regulatory and deployment significance with clear developer actions; reliance on mixed reporting sources limits absolute breakthrough claim.
Sources
Public references used for this report.
Practice interview problems based on real data
1,625 SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems
